BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 1, 2026
Home
»
Topics
»
Disease categories and therapies
» Dermatologic
Dermatologic
RSS
L.A.M. IPM Wound Gel to be launched in August 2002
July 1, 2002
Fibrostat efficacy and safety in scarring confirmed in phase II trial
June 28, 2002
Phase III program initiated for Actiza
June 28, 2002
Extina enters phase III for seborrheic dermatitis
June 17, 2002
Novogen initiates second clinical trial of NV-07a
June 17, 2002
Complete response letter issued for Amevive in psoriasis
June 14, 2002
Fujisawa to market Zindaclin in continental Europe
June 11, 2002
Dusa to reacquire rights to Levulan PDT from Schering AG
June 11, 2002
Corixa initiates U.S. study of PVAC in mild to moderate plaque psoriasis
June 7, 2002
Approval recommended for Amevive in psoriasis
May 24, 2002
Previous
1
2
…
344
345
346
347
348
349
350
351
352
…
447
448
Next
RSS